NEW YORK (GenomeWeb) – Cofactor Genomics has recently received a $1.5 million Phase II SBIR grant from the National Institutes of Health to further develop a circular RNA enrichment technology.

Circular RNA is noncoding, present in the cytoplasm, plays a role in neuronal development, and can serve as a biomarker for psychiatric disorders, according to Cofactor. In addition, circRNAs are present in lower abundance than other RNA molecules, and share sequence homology with mRNA, so they are difficult to isolate from total RNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.